[Form 4] Okta, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Okta Chief Legal Officer and Corporate Secretary Larissa Schwartz reported sales of Class A common stock on 09/17/2025 executed pursuant to a Rule 10b5-1 trading plan adopted on 09/30/2024. The filing shows two dispositions: 1,400 shares sold at a weighted average of $89.8257 and 1,948 shares sold at a weighted average of $90.4102, for a total of 3,348 shares sold. Remaining reported direct holdings after the transactions are shown as 41,103 and 39,155 shares in the respective table lines. The filing also discloses outstanding restricted stock units (RSUs) that vest on scheduled quarterly installments, with specific tranche sizes and vesting schedules noted.
Positive
- Transactions executed under Rule 10b5-1, indicating pre-planned, compliant insider trading
- Weighted-average sale prices disclosed with commitment to provide per-trade details upon request
- Detailed RSU vesting schedules provided showing transparency about future equity dilution
Negative
- Insider sold 3,348 shares which reduced direct holdings (reported post-transaction counts: 41,103 and 39,155)
- Sales included multiple price points, requiring further breakdown for precise per-trade analysis (footnotes indicate ranges)
Insights
TL;DR: Routine insider sales executed under a pre-existing 10b5-1 plan; transaction sizes are modest relative to typical company float.
The Form 4 documents two separate dispositions totaling 3,348 Class A shares executed on 09/17/2025 under a 10b5-1 plan adopted 09/30/2024. The filing provides weighted average sale prices of $89.8257 and $90.4102. These are disclosed sales, not option exercises, and the report includes the Reporting Person's remaining direct share counts and multiple RSU tranches with staged vesting. From an analytics perspective, this is a transparent, rule-compliant insider sale rather than an opportunistic or unexplained disposal.
TL;DR: Disclosure aligns with best practices: 10b5-1 plan noted and vesting schedules provided.
The Form 4 explicitly states the sales were effected pursuant to a Rule 10b5-1 trading plan and includes detailed footnotes on weighted average prices and vesting schedules for RSUs. Signature is by an attorney-in-fact, with the Reporting Person's title (Chief Legal Officer and Corporate Secretary) provided in remarks. Documentation appears complete for Section 16 reporting standards, meeting transparency expectations for insider transactions.